136 related articles for article (PubMed ID: 8680402)
1. Applications of heteroduplex analysis for mutation detection in disease genes.
Glavac D; Dean M
Hum Mutat; 1995; 6(4):281-7. PubMed ID: 8680402
[TBL] [Abstract][Full Text] [Related]
2. Identification of the commonest cystic fibrosis transmembrane regulator gene DeltaF508 mutation: evaluation of PCR--single-strand conformational polymorphism and polyacrylamide gel electrophoresis.
Kakavas KV; Noulas AV; Kanakis I; Bonanou S; Karamanos NK
Biomed Chromatogr; 2006 Oct; 20(10):1120-5. PubMed ID: 16708396
[TBL] [Abstract][Full Text] [Related]
3. CFTR mutation detection by multiplex heteroduplex (mHET) analysis on MDE gel.
Zielenski J; Aznarez I; Onay T; Tzounzouris J; Markiewicz D; Tsui LC
Methods Mol Med; 2002; 70():3-19. PubMed ID: 11917532
[No Abstract] [Full Text] [Related]
4. Mutation detection by denaturing DNA chromatography using fluorescently labeled polymerase chain reaction products.
Hecker KH; Taylor PD; Gjerde DT
Anal Biochem; 1999 Aug; 272(2):156-64. PubMed ID: 10415084
[TBL] [Abstract][Full Text] [Related]
5. Single-strand conformation polymorphism and heteroduplex analysis for gel-based mutation detection.
Nataraj AJ; Olivos-Glander I; Kusukawa N; Highsmith WE
Electrophoresis; 1999 Jun; 20(6):1177-85. PubMed ID: 10380757
[TBL] [Abstract][Full Text] [Related]
6. Comparison of heteroduplex and single-strand conformation analyses, followed by ethidium fluorescence visualization, for the detection of mutations in four human genes.
Rossetti S; Corrà S; Biasi MO; Turco AE; Pignatti PF
Mol Cell Probes; 1995 Jun; 9(3):195-200. PubMed ID: 7477013
[TBL] [Abstract][Full Text] [Related]
7. Cystic fibrosis mutation frequencies in upstate New York.
Shrimpton AE; Borowitz D; Swender P
Hum Mutat; 1997; 10(6):436-42. PubMed ID: 9401006
[TBL] [Abstract][Full Text] [Related]
8. SSCP analysis: a blind sensitivity trial.
Jordanova A; Kalaydjieva L; Savov A; Claustres M; Schwarz M; Estivill X; Angelicheva D; Haworth A; Casals T; Kremensky I
Hum Mutat; 1997; 10(1):65-70. PubMed ID: 9222762
[TBL] [Abstract][Full Text] [Related]
9. Biosensor technology for real-time detection of the cystic fibrosis W1282X mutation in CFTR.
Feriotto G; Ferlini A; Ravani A; Calzolari E; Mischiati C; Bianchi N; Gambari R
Hum Mutat; 2001; 18(1):70-81. PubMed ID: 11438995
[TBL] [Abstract][Full Text] [Related]
10. DHPLC screening of cystic fibrosis gene mutations.
Ravnik-Glavac M; Atkinson A; Glavac D; Dean M
Hum Mutat; 2002 Apr; 19(4):374-83. PubMed ID: 11933191
[TBL] [Abstract][Full Text] [Related]
11. Rapid detection of exon 1 NRAS gene mutations using universal heteroduplex generator technology.
Belli C; De Brasi C; Larripa I
Hum Mutat; 2003 Feb; 21(2):132-7. PubMed ID: 12552560
[TBL] [Abstract][Full Text] [Related]
12. High sensitivity of detection of TP53 somatic mutations by fluorescence-assisted mismatch analysis.
Tessitore A; Di Rocco ZC; Cannita K; Ricevuto E; Toniato E; Tosi M; Ficorella C; Frati L; Gulino A; Marchetti P; Martinotti S
Genes Chromosomes Cancer; 2002 Sep; 35(1):86-91. PubMed ID: 12203794
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
[TBL] [Abstract][Full Text] [Related]
14. An improved high throughput heteroduplex mutation detection system for screening BRCA2 mutations-fluorescent mutation detection (F-MD).
Edwards SM; Kote-Jarai Z; Hamoudi R; Eeles RA
Hum Mutat; 2001 Mar; 17(3):220-32. PubMed ID: 11241844
[TBL] [Abstract][Full Text] [Related]
15. Extended gene analysis can increase specificity of neonatal screening for cystic fibrosis.
Mérelle ME; Scheffer H; De Jong D; Dankert-Roelse JE
Acta Paediatr; 2006 Nov; 95(11):1424-8. PubMed ID: 17062471
[TBL] [Abstract][Full Text] [Related]
16. Direct genomic multiplex PCR for BRCA1 and application to mutation detection by single-strand conformation and heteroduplex analysis.
Barker DF
Hum Mutat; 2000 Oct; 16(4):334-44. PubMed ID: 11013444
[TBL] [Abstract][Full Text] [Related]
17. SSCP/heteroduplex analysis.
Wallace AJ
Methods Mol Biol; 2002; 187():151-63. PubMed ID: 12013742
[No Abstract] [Full Text] [Related]
18. Molecular analysis using DHPLC of cystic fibrosis: increase of the mutation detection rate among the affected population in Central Italy.
D'Apice MR; Gambardella S; Bengala M; Russo S; Nardone AM; Lucidi V; Sangiuolo F; Novelli G
BMC Med Genet; 2004 Apr; 5():8. PubMed ID: 15084222
[TBL] [Abstract][Full Text] [Related]
19. NF1 mutation analysis using a combined heteroduplex/SSCP approach.
Abernathy CR; Rasmussen SA; Stalker HJ; Zori R; Driscoll DJ; Williams CA; Kousseff BG; Wallace MR
Hum Mutat; 1997; 9(6):548-54. PubMed ID: 9195229
[TBL] [Abstract][Full Text] [Related]
20. Genetic screening and testing by induced heteroduplex formation.
Wood N; Bidwell J
Electrophoresis; 1996 Jan; 17(1):247-54. PubMed ID: 8907549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
